Oral and Maxillofacial Hemangioma Laser Treatment

Oral and Maxillofacial Hemangiomas (OHs) are benign tumors that form in and around the oral cavity as a result of endothelial cell growth.

Oral and Maxillofacial Hemangiomas are relatively rare and most commonly include the lips, tongue, buccal mucosa, and palate. While 60 to 70% of hemangiomas originate in the head and neck area, OHs are very rare and most commonly involve the lips, tongue, buccal mucosa, and palate.

Although there are many treatment approaches for curing this lesion such as; surgery, cryotherapy, sclerosant agents, laser therapy has more advantages in comparison to the other methods. Such as hemostasis and clean operating field, decreased amount of pain and oedema.

Several laser devices are continually being developed to carry out these duties. Maxillofacial surgeons have traditionally preferred the FDA Portable Surgery Diode Laser System LASER-1.2B.

This device displays a unique feature. Its blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm, this machine can perform better and gentler benign tumors’ cutting, even at lower power.

As such, its improved cutting performance makes it ideally suited to all surgical applications, particularly for Oral and Maxillofacial benign tumors.

The LASER-1.2B is also highly recommended by maxillofacial surgeons because it provides precise alignment and sighting during treatment/surgery. Its green targeting laser is to thank for this.

Also, for better results, the device is supported with a fibre guide laser. So, it is compatible with various endoscopic uses.

Furthermore, these unique fibres are sterilisable, preventing any potential cross-infection and ensuring a clean and bloodless operating room.

With 980 nm wavelength and 15W as maximum power, the device is thought to perfectly suit this benign tumor quite sensitive surgeries.

Such a quality is also expected to reduce thermal damage due to its peculiar interaction with haemoglobin.

All of these properties ensure that LASER-1.2 B’s cutting efficacy is significantly higher than that of infrared lasers.

Since their invention, laser applications have expanded rapidly as they proved to be a successful addition to cancer/benign tumors surgeries.  

The advantages of laser treatment are discussed in this article, as well as the efficacy of the SIFLASER-1.2B as a surgical laser device in treating Oral and Maxillofacial Hemangioma.

Reference: Laser Treatment of Oral and Maxillofacial Hemangioma

Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFLASER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.

The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.